Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb V To the active ingredient aclidinium bromide, Atc R03bb05 For The Time 01.05.2023 - 30.04.2025 (1003891-aclidinium bromide, Atc R03bb05)
Closing Date5 Mar 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Betahistin, Atc N07ca01 Für Die Zeit 01.02.2024 - 31.01.2026
Closing Date5 Dec 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 Sgb V for the active substance teriflunomide, Atc L04aa31 for the period 10/01/2023 - 09/30/2025 (1004033 - teriflunomide, Atc L04aa31)
Closing Date5 Aug 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 May 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Sofosbuvir Und Velpatasvir, Atc J05ap55 Für Die Zeit 01.05.2024 - 30.04.2026
Closing Date5 Mar 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Albendazol, Atc P02ca03 (obg) Für Die Zeit 01.08.2024 - 31.07.2026
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine...+1Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient naloxegol, ATC A06AH03 (obo) for the period 01.08.2024 - 31.07.2026
Closing Date5 Jun 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Benralizumab, Atc R03dx10 For The Time 01.06.2023 - 31.05.2025
Closing Date5 Apr 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient allergen extract from birch pollen, Atc V01aa05 for the period November 1st, 2023 - October 31st, 2025
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient albendazole, ATC P02ca03 (obg) for the period 01.08.2024 - 31.07.2026
Closing Date5 Jun 2026
Tender AmountRefer Documents 
21-30 of 342 active Tenders